High dose short term glucocorticoid (gc) treatment seems to have no long term negative effect on bone mineral density (bmd) of newly diagnosed multiple sclerosis (ms) patients
George Simeakis(404 General Military Hospital), Evangelos Terpos(National and Kapodistrian University of Athens), Αθανάσιος Παπαθεοδώρου(Hellenic Air Force), Maria Alevizaki(National and Kapodistrian University of Athens), Maria Anagnostouli(National and Kapodistrian University of Athens), John Koutsikos(401 General Military Hospital of Athens), Kostas Athanasiou, Katerina Saltiki(Alexandra Hospital), Evangelia Zapanti(National and Kapodistrian University of Athens), Nikolaos Fakas, George Papatheodorou(University of Patras)
Cited by 0
Related Papers
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
|Journal of the American Academy of Child & Adolescent Psychiatry|2001|648
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
|European Journal of Endocrinology|2009|459
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
|Journal of Clinical Oncology|2010|409